Skip to main content
. 2012 Nov 28;5:409–416. doi: 10.2147/OTT.S36330

Figure 2.

Figure 2

Kaplan–Meier progression-free survival curves for patients undergoing treatment with SSAs according to p-AKT (A) and p-S6 (B) expression scores.

Notes: Low p-AKT and p-S6 corresponds to absent/weak staining score; high p-AKT and p-S6 corresponds to moderate/strong staining score. P-values were calculated using a log-rank test.

Abbreviation: SSAs, somatostatin analogs.